<unk>  is a tumor necrosis factor blocker that is FDA approved for the treatment of crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include rash, abdominal pain, nausea, headache, pharyngitis, respiratory tract infection, fatigue, fever.
Infliximab
Basiliximab
Abciximab
Anakinra
Canakinumab
Belatacept
Vedolizumab
Briakinumab